Cargando…

Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis

BACKGROUND: Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Vianello, Elena, Dogliotti, Giada, Dozio, Elena, Romanelli, Massimiliano Marco Corsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575247/
https://www.ncbi.nlm.nih.gov/pubmed/23339583
http://dx.doi.org/10.1186/1742-4933-10-2
_version_ 1782259681434009600
author Vianello, Elena
Dogliotti, Giada
Dozio, Elena
Romanelli, Massimiliano Marco Corsi
author_facet Vianello, Elena
Dogliotti, Giada
Dozio, Elena
Romanelli, Massimiliano Marco Corsi
author_sort Vianello, Elena
collection PubMed
description BACKGROUND: Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect are not well known. Since heart-type fatty acid binding protein (H-FABP) is a protein involved in the transport of fatty acids and it has been recently correlated with the presence of atherosclerosis, we aimed to measure H-FABP level both in DS and in healthy subjects during aging to evaluate the association between this molecule, aging and atherosclerosis. FINDINGS: We quantified plasmatic H-FABP level in three groups of male DS and age-matched healthy subjects (children, age 2–14 years; adults, age 20–50 years; elderly, > 60 years) using a biochip array analyzer. We observed that aging is associated with increased H-FABP level in healthy subjects but not in DS which display both the same protein level in the different ages of life and have also lower level compared to their age-matched healthy subjects. CONCLUSION: Reduced H-FABP level during aging in DS may play a protective role against atherosclerosis. The potential involvement of H-FABP in the relationship between aging, atherosclerosis and development of coronary artery disease needs further investigations.
format Online
Article
Text
id pubmed-3575247
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35752472013-02-19 Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis Vianello, Elena Dogliotti, Giada Dozio, Elena Romanelli, Massimiliano Marco Corsi Immun Ageing Short Report BACKGROUND: Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect are not well known. Since heart-type fatty acid binding protein (H-FABP) is a protein involved in the transport of fatty acids and it has been recently correlated with the presence of atherosclerosis, we aimed to measure H-FABP level both in DS and in healthy subjects during aging to evaluate the association between this molecule, aging and atherosclerosis. FINDINGS: We quantified plasmatic H-FABP level in three groups of male DS and age-matched healthy subjects (children, age 2–14 years; adults, age 20–50 years; elderly, > 60 years) using a biochip array analyzer. We observed that aging is associated with increased H-FABP level in healthy subjects but not in DS which display both the same protein level in the different ages of life and have also lower level compared to their age-matched healthy subjects. CONCLUSION: Reduced H-FABP level during aging in DS may play a protective role against atherosclerosis. The potential involvement of H-FABP in the relationship between aging, atherosclerosis and development of coronary artery disease needs further investigations. BioMed Central 2013-01-22 /pmc/articles/PMC3575247/ /pubmed/23339583 http://dx.doi.org/10.1186/1742-4933-10-2 Text en Copyright ©2013 Vianello et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Vianello, Elena
Dogliotti, Giada
Dozio, Elena
Romanelli, Massimiliano Marco Corsi
Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
title Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
title_full Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
title_fullStr Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
title_full_unstemmed Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
title_short Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
title_sort low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575247/
https://www.ncbi.nlm.nih.gov/pubmed/23339583
http://dx.doi.org/10.1186/1742-4933-10-2
work_keys_str_mv AT vianelloelena lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis
AT dogliottigiada lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis
AT dozioelena lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis
AT romanellimassimilianomarcocorsi lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis